Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review

Mucopolysaccharidosis type 2 is a congenital lysosomal disease characterized by iduronate-2-sulfatase deficiency, which leads to excessive accumulation of glycosaminoglycans in tissue. Dysostosis, which primarily involves decreased bone mineralization with morphological changes in the bone, is a maj...

Full description

Bibliographic Details
Main Authors: Tomoaki Sasaki, MD, PhD, Miki Ogata, MD, Aya Kajihama, MD, Kouichi Nakau, MD, Atsutaka Okizaki, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043321000030
id doaj-e87b21e82e2b4ef3aa060a06e2b0694e
record_format Article
spelling doaj-e87b21e82e2b4ef3aa060a06e2b0694e2021-01-24T04:27:25ZengElsevierRadiology Case Reports1930-04332021-03-01163656660Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature reviewTomoaki Sasaki, MD, PhD0Miki Ogata, MD1Aya Kajihama, MD2Kouichi Nakau, MD3Atsutaka Okizaki, MD, PhD4Department of Radiological Technology, Graduate School of Health Sciences, Okayama University, 2-5-1, Shikata-cho, Kita-ku, Okayama 700-8558, Japan; Corresponding author.Department of Radiology, Asahikawa Medical University, Asahikawa, JapanDepartment of Pediatrics, Asahikawa Medical University, Asahikawa, JapanDepartment of Pediatrics, Asahikawa Medical University, Asahikawa, JapanDepartment of Radiology, Asahikawa Medical University, Asahikawa, JapanMucopolysaccharidosis type 2 is a congenital lysosomal disease characterized by iduronate-2-sulfatase deficiency, which leads to excessive accumulation of glycosaminoglycans in tissue. Dysostosis, which primarily involves decreased bone mineralization with morphological changes in the bone, is a major skeletal condition in mucopolysaccharidosis, but its pathophysiology is not well known. Here, we report a case of mucopolysaccharidosis type 2 diagnosed at the age of 2 years with longitudinal follow-up data for more than 15 years. Although the patient underwent bone marrow transplantation, the developmental quotient did not improve, and cranial hyperostosis progressed prominently with a faintly dilated perivascular space. Other dysostoses and contraction of the joints were observed but did not improve either.http://www.sciencedirect.com/science/article/pii/S1930043321000030Mucopolysaccharidosis type 2DysostosisCranial hyperostosis
collection DOAJ
language English
format Article
sources DOAJ
author Tomoaki Sasaki, MD, PhD
Miki Ogata, MD
Aya Kajihama, MD
Kouichi Nakau, MD
Atsutaka Okizaki, MD, PhD
spellingShingle Tomoaki Sasaki, MD, PhD
Miki Ogata, MD
Aya Kajihama, MD
Kouichi Nakau, MD
Atsutaka Okizaki, MD, PhD
Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
Radiology Case Reports
Mucopolysaccharidosis type 2
Dysostosis
Cranial hyperostosis
author_facet Tomoaki Sasaki, MD, PhD
Miki Ogata, MD
Aya Kajihama, MD
Kouichi Nakau, MD
Atsutaka Okizaki, MD, PhD
author_sort Tomoaki Sasaki, MD, PhD
title Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
title_short Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
title_full Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
title_fullStr Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
title_full_unstemmed Dysostosis in mucopolysaccharidosis type 2: A case of longitudinal follow up and literature review
title_sort dysostosis in mucopolysaccharidosis type 2: a case of longitudinal follow up and literature review
publisher Elsevier
series Radiology Case Reports
issn 1930-0433
publishDate 2021-03-01
description Mucopolysaccharidosis type 2 is a congenital lysosomal disease characterized by iduronate-2-sulfatase deficiency, which leads to excessive accumulation of glycosaminoglycans in tissue. Dysostosis, which primarily involves decreased bone mineralization with morphological changes in the bone, is a major skeletal condition in mucopolysaccharidosis, but its pathophysiology is not well known. Here, we report a case of mucopolysaccharidosis type 2 diagnosed at the age of 2 years with longitudinal follow-up data for more than 15 years. Although the patient underwent bone marrow transplantation, the developmental quotient did not improve, and cranial hyperostosis progressed prominently with a faintly dilated perivascular space. Other dysostoses and contraction of the joints were observed but did not improve either.
topic Mucopolysaccharidosis type 2
Dysostosis
Cranial hyperostosis
url http://www.sciencedirect.com/science/article/pii/S1930043321000030
work_keys_str_mv AT tomoakisasakimdphd dysostosisinmucopolysaccharidosistype2acaseoflongitudinalfollowupandliteraturereview
AT mikiogatamd dysostosisinmucopolysaccharidosistype2acaseoflongitudinalfollowupandliteraturereview
AT ayakajihamamd dysostosisinmucopolysaccharidosistype2acaseoflongitudinalfollowupandliteraturereview
AT kouichinakaumd dysostosisinmucopolysaccharidosistype2acaseoflongitudinalfollowupandliteraturereview
AT atsutakaokizakimdphd dysostosisinmucopolysaccharidosistype2acaseoflongitudinalfollowupandliteraturereview
_version_ 1724326794489757696